NCT03664193View on ClinicalTrials.gov

MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 24, 2018

Primary Completion Date

January 28, 2020

Study Completion Date

January 28, 2020

Conditions
Prostate Cancer
Interventions
RADIATION

SIBRT

Patients will receive 35 Gy in 5 fractions. Also, patients will receive 0.5-2 Gy per fx for a total dose of 37.5, 40, 42.5, or 45 Gy. Patients will also have an option to have a rectal balloon or a rectal spacer prior to receiving radiation therapy.

Trial Locations (1)

10065

Weill Cornell Medicine, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT03664193 - MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer | Biotech Hunter | Biotech Hunter